CSRxP ANALYSIS FINDS PHARMACEUTICAL INDUSTRY’S PROFIT MARGINS TEN TIMES GREATER THAN OTHER SECTORS OF DRUG SUPPLY CHAIN
Nov 20, 2024
Study Finds Big Pharma’s Price-Gouging and Patent Abuse Playbook Fuels… Read More
© 2024 CSRXP- All Rights Reserved
Press & Statements
CSRxP: SENATE JUDICIARY COMMITTEE SHOULD REJECT PHARMA-SUPPORTED POLICIES THAT WOULD UNDERMINE BIPARTISAN PROGRESS ON PATENT ABUSE
Nov 12, 2024
Lawmakers Should Remain Focused on Holding Big Pharma Accountable for… Read More
CSRxP: SENATE JUDICIARY COMMITTEE SHOULD REJECT PHARMA-SUPPORTED POLICIES THAT WOULD UNDERMINE BIPARTISAN PROGRESS ON PATENT ABUSE
Sep 25, 2024
Lawmakers Should Remain Focused on Holding Big Pharma Accountable for… Read More
CSRxP ENCOURAGES HELP COMMITTEE TO ADVANCE BIPARTISAN SOLUTIONS TO PROMOTE GREATER COMPETITION IN THE PRESCRIPTION DRUG MARKET
Sep 24, 2024
Legislation Scheduled for Thursday Markup Would Encourage Adoption of… Read More
CSRxP: BIG PHARMA’S EGREGIOUS GLP-1 PRICES AND ANTI-COMPETITIVE TACTICS UNSUSTAINABLE FOR PATIENTS AND U.S. HEALTH CARE SYSTEM
Sep 24, 2024
HELP Committee Hearing an Opportunity to Highlight Staggering Cost… Read More
CSRxP JOINS FELLOW ADVOCATES FOR LOWER DRUG PRICES TO URGE HOUSE JUDICIARY COMMITTEE TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE
Sep 6, 2024
Letter Encourages Lawmakers to Advance Bipartisan Solutions to Hold Big Pharma… Read More
CSRxP Launches Seven-Figure Advertising Campaign to Hold Big Pharma Accountable for Egregious Drug Prices, Anti-Competitive Tactics and False Rhetoric
Sep 4, 2024
Campaign Will Add Support to Growing Bipartisan Momentum to Crack Down on Big… Read More
CSRxP: Eli Lilly’s Zepbound Announcement Leaves Prices High for Most Patients, Serves as Powerful Reminder Big Pharma Alone Sets Prices
Aug 27, 2024
Lowering Prices for Some Patients at Some Dosages Will Have Limited Impact,… Read More
CSRxP APPLAUDS REINTRODUCTION OF REMEDY ACT IN U.S. SENATE
Jul 31, 2024
Bipartisan, Market-Based Solution Would Help Crack Down on Anti-Competitive… Read More
CSRXP: BIG PHARMA IS AT IT AGAIN, HIKES PRICES ON NEARLY 200 PRESCRIPTION DRUGS AS PART OF MID-YEAR INCREASES
Jul 15, 2024
Brand Name Drug Giants’ Average Price Increases for June-July Outpace Rate… Read More
CSRXP APPLAUDS U.S. SENATE PASSAGE OF BIPARTISAN, MARKET-BASED SOLUTION TO CRACK DOWN ON BIG PHARMA’S PATENT THICKETS
Jul 11, 2024
Legislation Would Hold Big Pharma Accountable for Anti-Competitive Tactics… Read More
NEW GOODRX REPORT UNDERSCORES NEED FOR CONGRESS TO HOLD BIG PHARMA ACCOUNTABLE
Jul 2, 2024
Latest Data Finds List Prices of Prescription Drug Prices Have Increased… Read More